3. The Pharmaceutical Industry in India is one of the largest in
the world.
It ranks 4th in the world, pertaining to the volume of sales.
The estimated worth of the Indian Pharmaceutical Industry is
US$ 6billion.
In 2008, the domestic pharmaceuticals market in India was
expected to be US$ 10.76 billion and this is likely to increase
at a compound annual growth rate of 9.9 per cent until 2010
and subsequently at 9.5per cent till the year 2015.
The Indian Pharmaceutical Industry is one of the biggest
producers of the active Pharmaceutical ingredients (API) in
the international arena.
5. The Indian Pharmaceuticals Industry includes small
scaled, medium scaled, large scaled players, which
totals nearly 300different companies.
There are several other small units operating in the
domestic sector.
The sales of the Indian Pharmaceutical Industry
would be worth US$ 43billion within the next decade.
The Pharmaceuticals Industry in India produces
around 20%to 24% of the global generic drugs.
6. Dr.REDDY’S LAB
►ESTABLISHED IN 1984
Dr.ANJI REDDY
Doctorate from the national chemical
laboratory,pune
TOP PHARMACEUTICAL COMPANY
IN THE COUNTRY
7. Established in 1984, Dr. Reddy·s Laboratories (NYSERDY) is an
emerging global pharmaceutical company.
Dr. Reddy·s products are marketed globally, with a focus on India, US,
europe and Russia.
Dr. Reddy·s conducts research in the areas of metabolic disorders,
cardiovascular indications, anti-infective and inflammation
The company has 60 active pharmaceutical ingredients to
manufacture drugs, critical care products, diagnostic kits and
biotechnology products.
The company has 6 FDA plants that produce active pharma
ingredients and 7 FDA inspected and ISO 9001 and ISO 14001certified
plants.
8.
9. ACHIEVEMENTS
Padma shri in 2001.
Dr. K. Anji reddy is also
a philanthropist.
Dr. K. Anji reddy has
received many awards
and honors
10. ► 7500 employees working across the
globe in more than 35 countries
MD----SATISH KUMAR
TURNOVER OF RS. 537.70
CRORES
11. TOP COMPANIES
♣ RANBAXY LABORATORIES
♣ CIPLA
♣ DR.REDDY'S LABORATORIES
♣ NICHOLAS PIRAMAL
♣ AUROBINDO PHARMA
♣ LUPIN
♣ CADILA HEALTHCARE
♣ SUN PHARMACEUTICAL
♣ WOCKHARDT and
♣ ORCHID CHEMICAL
12. HIS
QUALITIES
► Great man with the determination.
► Brave man who works while others
sleep
► Thinking is the capital enterprise
►Sweat for the great vision
13. ► 1300 people in the campus
recruitment.
► 1/3 is the women
►“Mr Prabir Kumar Jha, Senior Vice-
President and Global Head of Human
Resources” said the information.
17. Dr Reddy's Laboratories remained on top with consolidated
net sales of Rs 5,283 crore during the nine months ended
December 2009 as against Rs 4,862 crore in the same period
of last year indicating a relatively lower growth of 8.7 per cent.
Dr. Reddy·s forayed into the rural markets in FY09 with
launch of an exclusive portfolio of products targeted at the
needs of people in rural India.
Adjusted EBITDA of Rs. 15,828 million is highest among
pharmaceutical companies in India in the year 2009-10.
In 2009-10, share of revenue from the international
businesses stood at 82%, with 18% coming from India.
18. Ratio analysis
Year 2012 2011 2010 2009
Current
1.7 1.66 1.49 1.85
Ratio
Quick Ratio 1.84 1.91 1.45 2.13
Debt Equity
0.23 0.24 0.1 0.12
Ratio
19.
20. Dr Reddy's Laboratories remained on top with consolidated
net sales of Rs 5,283 crore during the nine months ended
December 2009 as against Rs 4,862 crore in the same period
of last year indicating a relatively lower growth of 8.7 per cent.
Dr. Reddy·s forayed into the rural markets in FY09 with
launch of an exclusive portfolio of products targeted at the
needs of people in rural India.
Adjusted EBITDA of Rs. 15,828 million is highest among
pharmaceutical companies in India in the year 2009-10.
In 2009-10, share of revenue from the international
businesses stood at 82%, with 18% coming from India.
21. PROFITABILITY RATIOS
2012 2011
Profit margin 17.42 24.76
Return on assets 286.12 350.30
Return on equity 10.55 15.87
Assets turnover 1.97 1.86
Earning per share 28.26 50.11
